Breaking News Instant updates and real-time market news.

MCK

McKesson

$138.53

0.25 (0.18%)

11:41
07/10/18
07/10
11:41
07/10/18
11:41

McKesson upgraded to Buy from Hold at Standpoint Research

  • 26

    Jul

MCK McKesson
$138.53

0.25 (0.18%)

06/29/18
RBCM
06/29/18
NO CHANGE
Target $158
RBCM
Sector Perform
McKesson price target lowered to $158 from $170 at RBC Capital
RBC Capital analyst George Hill lowered his price target on McKesson (MCK) to $158 and kept his Sector Perform rating, saying he is reducing his target multiple by one turn as a result of Amazon's (AMZN) entry into the pharmacy space. Hilll notes that the Amazon announcement overshadowed McKesson's investor day, where the company highlighted its "sustainable" organic growth expectations and affirmed its guidance.
06/28/18
JPMS
06/28/18
NO CHANGE
JPMS
Amazon deal creates significant overhang on Rx channel sentiment, says JPMorgan
JPMorgan Analyst Lisa Gill said Amazon's (AMZN) agreement to acquire PillPack is expected to drive a "significant overhang" on sentiment across the prescription channel, even though she doesn't expect PillPack to capture a material share of the market in the near term. While the deal establishes an initial foothold for Amazon in the mail pharmacy space, she thinks it will take time to scale up and she does not believe PillPack's unit dose packaging technology is unique. Gill also noted that Express Scripts (ESRX) said it would remove PillPack from its pharmacy network in 2016 on allegations it had misrepresented itself as a retail pharmacy and not a mail pharmacy, though within weeks PillPack was added back by the PBM. Shares of retail pharmacy operators CVS Health (CVS), Walgreens (WBA) and Rite Aid (RAD) have all been pressured by the news of Amazon's deal, as have the shares of drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK). Diplomat Pharmacy (DPLO), an operator of a specialty pharmacy, is also sharply lower following the announcement from Amazon.
05/29/18
LEER
05/29/18
NO CHANGE
Target $160
LEER
Market Perform
McKesson price target lowered to $160 from $170 at Leerink
Leerink analyst David Larsen lowered his price target for McKesson to $160 from $170 saying he is slightly more cautious on the company and the drug distribution group following its earnings report and call. Continued commentary of stabilizing drug pricing trends bodes well for the group, but the analyst is still worry about renewals, generic pricing pressure, and a slowdown in list price inflation. Larsen reiterates a Market Perform rating on the shares.
04/17/18
MZHO
04/17/18
NO CHANGE
MZHO
Amazon news removes 'unprecedented overhang' on drug sellers, says Mizuho
After CNBC reported yesterday afternoon that Amazon (AMZN) has decided to shelve its plan to sell and distribute pharmaceutical products, Mizuho analyst Ann Hynes said she had thought Amazon's current logistics and distribution model would not translate into healthcare. However, based on conversations with investors, she believes the magnitude of the overhang that Amazon presented for drug distributors and retail pharmacies was "unprecedented." While drug pricing is still a concern, she notes that the CNBC report removes one overhang on the drug supply chain stocks. Hynes remain a buyer of CVS Health (CVS) and Walgreens (WBA) and keeps Neutral ratings on Rite Aid (RAD) as well as on drug distributors AmerisourceBergen (ABC), Cardinal Health (CAH) and McKesson (MCK).

TODAY'S FREE FLY STORIES

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

17:27
10/15/18
10/15
17:27
10/15/18
17:27
Syndicate
Breaking Syndicate news story on T2 Biosystems »

T2 Biosystems files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$36.43

-0.56 (-1.51%)

17:26
10/15/18
10/15
17:26
10/15/18
17:26
Initiation
Boston Scientific initiated  »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

BDX

Becton Dickinson

$238.38

-4.33 (-1.78%)

17:25
10/15/18
10/15
17:25
10/15/18
17:25
Initiation
Becton Dickinson initiated  »

Becton Dickinson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BAX

Baxter

$70.88

-0.39 (-0.55%)

17:24
10/15/18
10/15
17:24
10/15/18
17:24
Initiation
Baxter initiated  »

Baxter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 31

    Oct

CRMD

CorMedix

$2.15

-0.12 (-5.29%)

17:23
10/15/18
10/15
17:23
10/15/18
17:23
Syndicate
Breaking Syndicate news story on CorMedix »

CorMedix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVNS

Avanos

$60.02

0.59 (0.99%)

17:22
10/15/18
10/15
17:22
10/15/18
17:22
Initiation
Avanos initiated  »

Avanos initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$68.72

-0.62 (-0.89%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Initiation
Abbott initiated  »

Abbott initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SBBX

SB One Bancorp

$24.00

-0.27 (-1.11%)

17:19
10/15/18
10/15
17:19
10/15/18
17:19
Hot Stocks
Breaking Hot Stocks news story on SB One Bancorp »

EJF Capital reports 5.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:07
10/15/18
10/15
17:07
10/15/18
17:07
Hot Stocks
Hanwah Q Cells up 8.5% after agreeing to be acquired by Hanwha Solar »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.38

-0.005 (-0.36%)

17:06
10/15/18
10/15
17:06
10/15/18
17:06
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$30.64

0.42 (1.39%)

17:04
10/15/18
10/15
17:04
10/15/18
17:04
Earnings
CryoLife reports preliminary Q3 revenue $64.6M, consensus $61.84M »

Preliminary and unaudited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

, RIO

Rio Tinto

$49.54

0.34 (0.69%)

17:03
10/15/18
10/15
17:03
10/15/18
17:03
Hot Stocks
Turquoise Hill provides underground development update »

Turquoise Hill (TRQ)…

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

RIO

Rio Tinto

$49.54

0.34 (0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:02
10/15/18
10/15
17:02
10/15/18
17:02
Earnings
Palo Alto Networks backs Q1 EPS view $1.04-$1.06, consensus $1.06 »

Backs Q1 revenue view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Turquoise Hil reports Q3 throughput down 5% y/y »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

17:01
10/15/18
10/15
17:01
10/15/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Hanwah Q Cells »

Hanwha Q CELLS trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

17:00
10/15/18
10/15
17:00
10/15/18
17:00
Hot Stocks
Palo Alto Networks names Amit Singh as President »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

BCOR

Blucora

$32.96

-0.23 (-0.69%)

16:59
10/15/18
10/15
16:59
10/15/18
16:59
Hot Stocks
Blucora names Tran Taylor chief HR officer »

Blucora announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

16:56
10/15/18
10/15
16:56
10/15/18
16:56
Periodicals
Facebook to ban false information on voting ahead of midterms, Reuters says »

Facebook plans to ban…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

ADBE

Adobe

$238.05

-10.84 (-4.36%)

16:55
10/15/18
10/15
16:55
10/15/18
16:55
Conference/Events
Adobe to host financial analyst meeting »

Financial Analyst Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

LDOS

Leidos

$66.00

0.91 (1.40%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Hot Stocks
Leidos achieves CMMI Level 3 for Development »

Leidos announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AGN

Allergan

$183.03

-0.275 (-0.15%)

, ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

16:50
10/15/18
10/15
16:50
10/15/18
16:50
Conference/Events
Aclaris Therapeutics to host conference call »

Conference call to…

AGN

Allergan

$183.03

-0.275 (-0.15%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 30

    Oct

  • 27

    Nov

SEND

SendGrid

$30.94

0.04 (0.13%)

16:47
10/15/18
10/15
16:47
10/15/18
16:47
Hot Stocks
Breaking Hot Stocks news story on SendGrid »

SendGrid spikes up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Twilio to acquire SendGrid for $2B or $36.92 per share in all-stock deal »

Twilio (TWLO) and…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Hanwah Q Cells to be acquired by Hanwha Solar for ~ $825M equity value »

Hanwha Q CELLS announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

16:45
10/15/18
10/15
16:45
10/15/18
16:45
Hot Stocks
Tallgrass Energy increases quarterly dividend 2.5% »

Tallgrass Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.